Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,525 recalls · Class III, newest first

Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-912-01 D-1423-2015
Class III · Low risk

Phentermine Hydrochloride Capsules

Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station

Terminated Impurity / degradation KVK-Tech, Inc. NDC 10702-0026-01 D-1371-2015
Class III · Low risk

Intermezzo

Failed dissolution specifications

Terminated Dissolution failure Purdue Pharma L.P. NDC 59011-265-30 D-1278-2015
Class III · Low risk

Desmopressin Acetate Tablets

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Terminated Labeling / mix-up American Health Packaging D-1235-2015
Class III · Low risk

Desmopressin Acetate Tablets

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Terminated Labeling / mix-up Actavis Laboratories, FL, Inc. D-1285-2015
Class III · Low risk

Cortisol-Mc

Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.

Terminated Wrong potency / content Abrams Royal Pharmacy II, LLC NDC 88888-0043-31 D-1231-2015
Class III · Low risk

Disulfiram tablets

Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.

Terminated Dissolution failure Qualitest Pharmaceuticals NDC 0603-3432-21 D1151-2015
Class III · Low risk

Carb-O-Philic 40 Cream

CGMP Deviation: Poor container closure of the bulk storage container

Terminated Packaging defect Geritrex Corp NDC 54162-640-03 D-1238-2015
Class III · Low risk

Dr Blue Pain Relieving Gel

Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.

Terminated Wrong potency / content Indiana Botanic Gardens, Inc NDC 10578-035-05 D-1149-2015
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. D-1138-2015
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. D-1137-2015
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Terminated Impurity / degradation West-Ward Pharmaceutical Corp. NDC 0641-6028-25 D-1139-2015

Recalls by year